Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $3.12M | 8,209,725 | 0.87% | 99.13% | Net Selling | |||
| FBLG | FIBROBIOLOGICS INC | $12.97M | 51,456,077 | 7.35% | 12.05% | Net Buying | Net Buying | ||
| PSTV | PLUS THERAPEUTICS INC | $38.89M | 137,429,055 | 7.47% | 17.39% | Net Buying | |||
| RCKT | ROCKET PHARMACEUTICALS INC | $373.37M | 108,222,228 | 33.04% | 66.96% | Net Selling | Net Selling | ||
| NRXP | NRX PHARMACEUTICALS INC | $49.87M | 28,097,627 | 4.09% | 95.91% | ||||
| CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $7.10M | 11,454,512 | 11.79% | 0.00% | ||||
| NAKA | NAKAMOTO INC | $111.28M | 439,850,889 | 19.92% | 6.81% | Net Buying | |||
| OSTX | OS THERAPIES INC | $41.20M | 35,214,352 | 4.37% | 18.78% | Net Selling | |||
| SGMO | SANGAMO THERAPEUTICS INC | $122.15M | 336,494,489 | 12.84% | 9.48% | Net Selling | Net Selling | ||
| SLE | SUPER LEAGUE ENTERPRISE INC | $3.37M | 839,662 | 26.35% | 73.65% | Net Selling | Net Selling | ||
| TLRY | TILRAY BRANDS INC | $883.12M | 116,506,916 | 6.73% | 17.71% | Net Buying | Net Buying | ||
| PDSB | PDS BIOTECHNOLOGY CORP | $32.87M | 48,980,307 | 8.95% | 24.13% | Net Buying | |||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $29.34M | 115,058,619 | 6.18% | 9.28% | ||||
| GUTS | FRACTYL HEALTH INC | $57.70M | 137,044,440 | 50.12% | 21.22% | Net Buying | Net Buying | ||
| ACET | ADICET BIO INC | $67.62M | 9,578,474 | 15.41% | 84.59% | Net Buying | Net Selling | ||
| ENLV | ENLIVEX THERAPEUTICS LTD | $27.21M | 24,292,833 | 3.34% | 59.15% | ||||
| IFRX | INFLARX NV | $59.55M | 67,747,130 | 4.04% | 0.00% | ||||
| SNTI | SENTI BIOSCIENCES INC | $24.19M | 26,290,838 | 6.34% | 93.66% | Net Buying | |||
| TVRD | TVARDI THERAPEUTICS INC | $33.77M | 9,381,344 | 5.60% | 94.40% | Net Selling | |||
| VNRX | VOLITIONRX LTD | $26.40M | 122,801,572 | 3.27% | 31.35% | Net Buying | Net Selling | ||
| HUMA | HUMACYTE INC | $202.25M | 187,271,321 | 21.97% | 16.42% | Net Selling | |||
| PALI | PALISADE BIO INC | $251.82M | 149,003,210 | 16.71% | 5.57% | Net Buying | Net Buying | ||
| ACRV | ACRIVON THERAPEUTICS INC | $50.17M | 31,555,126 | 18.98% | 47.01% | Net Selling | Net Buying | ||
| TNYA | TENAYA THERAPEUTICS INC | $105.07M | 166,505,885 | 27.33% | 49.74% | Net Buying | Net Selling | ||
| CTSO | CYTOSORBENTS CORP | $40.70M | 62,804,305 | 25.42% | 45.21% | Net Buying | |||
| INTZ | INTRUSION INC | $17.93M | 20,102,939 | 6.93% | 75.71% | Net Buying | Net Selling | ||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $157.97M | 121,511,580 | 19.97% | 33.62% | Net Selling | |||
| CAN | CANAAN INC | $300.33M | 9,939,193,337 | 0.62% | 0.00% | ||||
| APRE | APREA THERAPEUTICS INC | $4.59M | 6,310,673 | 1.65% | 98.35% | Net Buying | Net Buying | ||
| MREO | MEREO BIOPHARMA GROUP PLC | $66.99M | 795,658,504 | 3.39% | 4.18% | ||||
| CABA | CABALETTA BIO INC | $301.31M | 96,265,204 | 27.64% | 4.52% | Net Buying | Net Buying | ||
| HOWL | WEREWOLF THERAPEUTICS INC | $31.99M | 48,540,200 | 8.29% | 88.70% | Net Selling | Net Selling | ||
| HELP | CYBIN INC | $354.25M | 49,894,131 | 19.77% | 0.00% | ||||
| TCRX | TSCAN THERAPEUTICS INC | $57.88M | 56,747,993 | 19.33% | 30.00% | Net Buying | Net Buying | ||
| LUNG | PULMONX CORP | $58.57M | 41,247,034 | 58.57% | 20.21% | Net Selling | Net Selling | ||
| CRBU | CARIBOU BIOSCIENCES INC | $151.42M | 93,468,038 | 26.39% | 8.81% | Net Buying | |||
| AUTL | AUTOLUS THERAPEUTICS PLC | $415.18M | 266,143,286 | 20.92% | 0.00% | ||||
| DARE | DARE BIOSCIENCE INC | $23.58M | 14,289,229 | 3.01% | 96.99% | ||||
| DEFT | DEFI TECHNOLOGIES INC | $271.75M | 384,375,991 | 4.43% | 0.00% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.